Sunday , August 20 2017
Home / Therapies / SGLT-2 Therapy Center / Christophe Arbet-Engels, MD, Q11: Is Empagliflozin Also Being Submitted Internationally?

Christophe Arbet-Engels, MD, Q11: Is Empagliflozin Also Being Submitted Internationally?

Dr. Christophe Arbet-Engels explains that Boehringer Ingelheim will also be submitting empagliflozin internationally, and certainly in the EU, and that they will also look carefully at all possibilities to submit the drug to other international authorities.

Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

See more SGLT-2 Resources